Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001235802-17-000023)

Filing Details

Accession Number:: 0001235802-17-000023
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-02-02 16:40:36
Reporting Period:: 2017-01-31

Filing Date:: 2017-02-02
Accepted Time:: 2017-02-02 16:40:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1374128	Entellus Medical Inc	ENTL	Surgical & Medical Instruments & Apparatus (3841)	204627978

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1428991	Essex Woodlands Health Ventures Fund Viii-A Lp	21 Waterway Avenue Suite 225 The Woodlands TX 77380		No	No	Yes	No
1428992	Essex Woodlands Health Ventures Fund Viii Lp	21 Waterway Avenue Suite 225 The Woodlands TX 77380		No	No	Yes	No
1452935	Essex Woodlands Health Ventures Fund Viii-B Lp	21 Waterway Avenue Suite 225 The Woodlands TX 77380		No	No	Yes	No
1632026	Essex Woodlands Health Ventures Viii, L.p.	21 Waterway Avenue Suite 225 The Woodlands TX 77380		No	No	Yes	No
1632027	Essex Woodlands Health Ventures Viii, L.l.c.	21 Waterway Avenue Suite 225 The Woodlands TX 77380		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	Disposition	2017-01-31	527,022	$17.00	2,928,689	No	4	S	Indirect	By Fund VIII
Common Stock, $0.001 Par Value	Disposition	2017-01-31	37,998	$17.00	211,159	No	4	S	Indirect	By Fund VIII-A
Common Stock, $0.001 Par Value	Disposition	2017-01-31	16,521	$17.00	91,808	No	4	S	Indirect	By Fund VIII-B

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Fund VIII
No	4	S	Indirect	By Fund VIII-A
No	4	S	Indirect	By Fund VIII-B

Footnotes

Represents a public offering price of $17.00 per share before underwriting discounts and commissions pursuant to an Underwriting Agreement dated January 25, 2017, which offering closed on January 31, 2017.
See Exhibit 99.1.
Each individual Manager and the General Partner disclaims beneficial ownership over the shares except to the extent of his or its respective pecuniary interest therein.